Aminoglycoside-induced hearing loss : South Africans at risk

Date
2009
Authors
Bardien, Soraya
De Jong, Greetje
Schaaf, H. Simon
Harris, Tashneem
Fagan, Johan
Petersen, Lucretia
Journal Title
Journal ISSN
Volume Title
Publisher
Health and Medical Publishing Group (HMPG)
Abstract
Description
Editorial
The original publication is available at http://www.samj.org.za
Bibliography
Keywords
acetylsalicylic acid; amikacin; aminoglycoside antibiotic agent; antimalarial agent; capreomycin; gentamicin; kanamycin; loop diuretic agent; mitochondrial DNA; polypeptide antibiotic agent; streptomycin; tuberculostatic agent; antibiotic resistance; antibiotic sensitivity; clinical trial; cost effectiveness analysis; drug potentiation; editorial; extensively drug resistant tuberculosis; gene mutation; genetic counseling; genetic screening; hearing loss; human; inner ear disease; multidrug resistant tuberculosis; nephrotoxicity; ototoxicity; patient compliance; race difference; risk assessment; risk factor; short course therapy; South Africa; treatment duration; treatment response; tuberculosis; tuberculosis control; vestibular disorder; Aminoglycosides; Anti-Bacterial Agents; Genetic Predisposition to Disease; Genetic Screening; Hearing Loss; Humans; Risk Factors; Tuberculosis, Multidrug-Resistant, Mitochondrial deafness -- Diagnosis -- South Africa, Antibiotic resistance -- Diagnosis, Antibiotic sensitivity, Multidrug resistant tuberculosis, Aminoglycoside - induced deafness
Citation
Bardien, S. et.al 2009, Aminoglycoside-induced hearing loss : South Africans at risk, SA Medical Journal, Vol.99, No.6, pp. 440-441, http://www.samj.org.za/index.php/samj